Seeking a Novel Therapeutic Strategy of Eya2/Brd4 Axis for the Treatment of Non-Small Cell Lung Cancer: Therapy for Drug Tolerant Persister Cells

Project: A - Government Institutionb - National Science and Technology Council

Project Details

Description

本研究計畫將為 DTP細胞-NSCLC 在 EGFR-TKI 耐藥中的分子機制提供新的見解,並有助於臨床前數據的轉化。
StatusFinished
Effective start/end date8/1/227/31/23

Keywords

  • Non-small cell lung cancer (NSCLC)
  • EYA2/BRD4 axis
  • Drug Tolerant Persister (DTP) cells
  • EGFR-TKI-resistance